The discussion highlights widespread expectations that venture funds raised in 2020 and 2021 will be 'tough vintages' due to deployment into a high-valuation environment. Many portfolio companies from this era, including 40% of US unicorns, have not raised capital since and remain overvalued on LP books, creating a significant performance and valuation overhang.
LPs are facing a dual challenge of overallocation to venture capital (the 'denominator effect') and a severe lack of distributions, resulting in approximately $200 billion in net negative cash flow since 2022. This has stalled the traditional capital recycling engine of the asset class and puts pressure on LPs to meet capital calls from existing commitments.
The market correction offers LPs a clear lens to assess GP quality beyond bull market returns. Key diligence factors now include a GP's valuation discipline during the 2021 peak, the speed of their capital deployment, and their behavior during down rounds, providing more robust data to underwrite managers for the long term.
The speakers contrast the advantages of large, scaled VC firms that offer extensive infrastructure and can 'weaponize the balance sheet' against smaller, often solo GP funds. While large firms have immense resources, smaller funds can offer more personal, authentic relationships, which can be a critical advantage for founders at the earliest stages.
The conversation identifies significant, albeit contrarian, opportunities in international venture markets, particularly China and India. China is described as 'capital starved' and a leader in robotics and open-source AI models, while India's exit market is projected to mature and become robust over the next decade.
Keep pulling the thread on Ed Grefenstette, Sean Warrington.